Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Someone loan me money...PLEASEEEE!!!!

I think Turley made a mistake yesterday in issuing the note to share holders.  What purpose did it serve.  Why didn't he simply release the same two press releases under PTSC website/PR channels, put PTSC's name in the title, and do it at the market open like Alliacense did.  There was no need to come out with a very vague note that makes it look like he's not in control of his own company.

Instead, they let Alliacense issue the PR with PTSC left out of the headline, mid morning he issues his note, and then long after the market closes, he had the PR's posted on the website finally, and still leaves PTSC out of the title of the release.  As CEO, Turley is to blame for that.  He has the ablility to approve the PR's per the master agreement just as TPL does.

Share
New Message
Please login to post a reply